Gracell Biotechnologies to Report Second Quarter Financial Results on Tuesday, August 17, 2021
August 03, 2021 09:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Fireside Chat at the BTIG Virtual Biotechnology Conference
July 26, 2021 09:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies Reschedules Clinical Update Conference Call and Webcast to June 14, 2021
June 02, 2021 08:30 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in Upcoming Virtual Conferences in June
May 25, 2021 16:01 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Host Clinical Update Conference Call and Webcast on June 4, 2021 at 11:00am EDT
May 21, 2021 08:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and PALO ALTO, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies Reports First Quarter 2021 Unaudited Financial Results and Provides Corporate Update
May 17, 2021 08:00 ET
|
Gracell Biotechnologies Inc.
Reported updated long-term follow-up data for TruUCAR-enabled CD7-targeted CAR-T product candidate GC027 for the treatment of T-ALL at AACR 2021 Annual Meeting Signed agreement with Lonza to...
Gracell Biotechnologies to Participate in Upcoming Virtual Conferences in May
April 30, 2021 17:32 ET
|
Gracell Biotechnologies Inc.
SUZHOU and SHANGHAI, China, April 30, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and...
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2020
April 23, 2021 18:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU and SHANGHAI, China, April 23, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing...
Gracell Biotechnologies to Present at the 20th Annual Needham Virtual Healthcare Conference
April 05, 2021 08:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU, China and SHANGHAI, China, April 05, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to...
Gracell Biotechnologies to Participate in the 2021 Virtual Wells Fargo Biotech Corporate Access Day
March 17, 2021 08:00 ET
|
Gracell Biotechnologies Inc.
SUZHOU and SHANGHAI, China, March 17, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and...